Autism Risk May Rise With In Utero Exposure to Antiseizure Meds
The incidence of autism spectrum disorder is higher among children exposed to topiramate in the second half of pregnancy.
Stay updated with breaking news from Sonia Hern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The incidence of autism spectrum disorder is higher among children exposed to topiramate in the second half of pregnancy.
New research shows use of the drugs in pregnancy is on the rise, particularly in the United States, and although teratogenic risks appear low, limitations are notable.
Recent research has found that the use of GLP-1 receptor agonists such as Ozempic during pregnancy is no more likely to lead to congenital malformations in infants than insulin use.
The exhibition at the Guadalupe Cultural Arts Center's Community Gallery opened Nov. 28 and runs through May 31, 2024.
Infants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during pregnancy are at no higher risk of major congenital malformations (MCMs) than infants born to those who take insulin, according to a new study led by Harvard T.H. Chan School of Public Health.